摘要
神经炎症在不同脑疾病中发挥很重要的作用包括急性脑损伤比如脑缺血中风、慢性神经变性疾病如阿尔兹海默症等。其中主要的作用是活化的小神经胶质能够产生大量加重疾病的促炎介质。与小神经胶质细胞活性相关的是以增生性星形胶质细胞为特征的星形胶质细胞,其具有促炎细胞因子、神经营养因子、干细胞、神经元和增生标记物,所有这些对损伤组织和神经功能的最终恢复的重建起到关键的作用。 在此,本文对脑疾病特别是脑缺血中的活化小胶质细胞和反应性星形胶质细胞的作用以及一种中国草药灯盏花的提取物对胶质细胞的作用。我们首先回顾了活化小胶质细胞和反应性星形胶质细胞之间的空间关系,因此它表明两者共同作用可用于组织重建和修复。其次,我们认为灯盏花是一种推定的治疗剂,因为发现它不仅能抑制小胶质细胞活化从而改善神经炎症,同时还能增加星形胶质细胞反应。最后,灯盏花乙素通过上调神经营养因子的表达来扩增星形细胞反应从而能表明其在神经保护方面的作用。很明显,灯盏花乙素在反应性星形胶质细胞上的作用是由支持两种胶质细胞之间的功能性“串扰”的活性小细胞胶质介导。本文强调了近期我们的发现关于说明灯盏花对脑缺血中的两种胶质细胞有益的作用从而提高神经性功能。
关键词: 灯盏花、脑缺血、活化小胶质细胞、反应性星形胶质细胞、抗炎、神经保护
Current Medicinal Chemistry
Title:Scutellarin Attenuates Microglia-Mediated Neuroinflammation and Promotes Astrogliosis in Cerebral Ischemia - A Therapeutic Consideration
Volume: 24 Issue: 7
关键词: 灯盏花、脑缺血、活化小胶质细胞、反应性星形胶质细胞、抗炎、神经保护
摘要: Neuroinflammation plays an important role in different brain diseases including acute brain injuries such as cerebral ischemic stroke and chronic neurodegenerative diseases e.g. Alzheimer’s disease etc. The central player in this is the activated microglia, which produce substantial amounts of proinflammatory mediators that may exacerbate the disease. Associated with microglia activation is astrogliosis characterized by hypertrophic astrocytes with increased expression of proinflammatory cytokines, neurotrophic factors, stem cell, neuronal and proliferation markers, all these are crucial for reconstruction of damaged tissue and ultimate restoration of neurological functions.
Here, we review the roles of activated microglia and reactive astrocytes in brain diseases with special reference to cerebral ischemia, and the effects of scutellarin, a Chinese herbal extract on both glial cells. We first reviewed the close spatial relation between activated microglia and reactive astrocytes as it suggests that both glial cells work in concert for tissue reconstruction and repair. Secondly, we have identified scutellarin as a putative therapeutic agent as it has been found to not only suppress microglial activation thus ameliorating neuroinflammation, but also enhance astrocytic reaction. In the latter, scutellarin amplified the astrocytic reaction by upregulating the expression of neurotrophic factors among others thus indicating its neuroprotective role. Remarkably, the effects of scutellarin on reactive astrocytes were mediated by activated microglia supporting a functional “cross-talk” between the two glial types. This review highlights some of our recent findings taking into consideration of others demonstrating the beneficial effects of scutellarin on both glial cell types in cerebral ischemia as manifested by improvement of neurological functions.Export Options
About this article
Cite this article as:
Scutellarin Attenuates Microglia-Mediated Neuroinflammation and Promotes Astrogliosis in Cerebral Ischemia - A Therapeutic Consideration, Current Medicinal Chemistry 2017; 24 (7) . https://dx.doi.org/10.2174/0929867324666161118142045
DOI https://dx.doi.org/10.2174/0929867324666161118142045 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Endocannabinoid System in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?
Current Drug Targets The Role of Wnt/Beta-Catenin Signaling in Renal Carcinogenesis: Lessons from Cadmium Toxicity Studies
Current Molecular Medicine The Applications of Pharmacogenomics to Neurological Disorders
Current Molecular Medicine FLT3 as a Therapeutic Target in Childhood Acute Leukemia
Current Drug Targets Restless Legs Syndrome/Willis-Ekbom Disease and Periodic Limb Movements: A Comprehensive Review of Epidemiology, Pathophysiology, Diagnosis and Treatment Considerations
Current Rheumatology Reviews Ghrelin as a Potential Anti-Obesity Target
Current Pharmaceutical Design Editorial (Hot Topic: Innovative Approaches for the Management of Pediatric Malignancies)
Current Medicinal Chemistry A Review on Post-traumatic Stress Disorder (PTSD): Symptoms, Therapies and Recent Case Studies
Current Molecular Pharmacology Anti-IL-1 β Therapies
Recent Patents on DNA & Gene Sequences Metformin - The Drug for the Treatment of Autoimmune Diseases; A New Use of a Known Anti-Diabetic Drug
Current Topics in Medicinal Chemistry Perinatal Exposure to Bisphenol A and Developmental Programming of the Cardiovascular Changes in the Offspring
Current Medicinal Chemistry Combined Chemotherapy or Biotherapy with Jasmonates: Targeting Energy Metabolism for Cancer Treatment
Current Pharmaceutical Biotechnology Molecular Genetics of Early- and Late-Onset Alzheimer’s Disease
Current Gene Therapy Detecting Gene-Gene Interactions Associated with Multiple Complex Traits with U-Statistics
Current Genomics Molecular Diagnosis in Autoimmune Skin Blistering Conditions
Current Molecular Medicine Vitamin D Analogs as Anti-Carcinogenic Agents
Anti-Cancer Agents in Medicinal Chemistry Sulfur-Containing Compounds in Protecting Against Oxidant-Mediated Lung Diseases
Current Medicinal Chemistry Using Biologic Agents in Pediatric Rheumatologic Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Delivery Systems for Applications in siRNA Technology
Drug Delivery Letters